Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,466.50
-0.50 (-0.03%)
Jul 30, 2025, 11:56 AM CET

Genmab Market Cap

Genmab has a market cap or net worth of 90.22 billion as of July 30, 2025. Its market cap has decreased by -20.93% in one year.

Market Cap
90.22B
Enterprise Value
68.95B
Revenue
22.30B
Ranking
n/a
PE Ratio
11.58
Stock Price
1,466.50

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 3.68B to 90.22B, an increase of 2,348.95%. That is a compound annual growth rate of 13.77%.

History

DateMarket Cap% Change
Jul 29, 202590.22B-4.84%
Dec 30, 202494.81B-32.65%
Dec 29, 2023140.77B-26.77%
Dec 30, 2022192.23B11.72%
Dec 30, 2021172.06B6.80%
Dec 30, 2020161.11B67.11%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Novo Nordisk2,006.90B
Coloplast139.24B
Demant59.60B
ALK-Abelló43.68B
H. Lundbeck33.89B
Ambu A/S27.04B
Zealand Pharma26.60B
Bavarian Nordic18.14B
Market Cap Rankings